Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.
Sweiss NJ, Noth I, Mirsaeidi M, Zhang W, Naureckas ET, Hogarth DK, Strek M, Caligiuri P, Machado RF, Niewold TB, Garcia JG, Pangan AL, Baughman RP.
Sweiss NJ, et al. Among authors: mirsaeidi m.
Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):46-54.
Sarcoidosis Vasc Diffuse Lung Dis. 2014.
PMID: 24751453
Free PMC article.
Clinical Trial.